Elisabeth Sandoval, Chief Commercial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 2,728 shares at $74.75 ($204K) on 2015-08-05, disclosed to the SEC on 2015-08-06.
Open-market sale of $204k KYTH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |